propranolol has been researched along with flecainide in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (23.08) | 18.7374 |
1990's | 10 (19.23) | 18.2507 |
2000's | 12 (23.08) | 29.6817 |
2010's | 15 (28.85) | 24.3611 |
2020's | 3 (5.77) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Dalvie, D; Loi, CM; Smith, DA | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hulkower, S; Kostic, B; Treakle, K | 1 |
Antzelevitch, C; Krishnan, SC | 1 |
Cheymol, G; Chézalviel, F; Davy, JM; Engel, F; Ertzbischoff, O; Lainée, P; Motté, G; Penin, E; Poirier, JM; Weissenburger, J | 1 |
Anderson, JL | 1 |
Bondke, H; Brinker, J; Datorre, SD; Guarnieri, T; Levine, JH; Myers, S | 1 |
Castellanos, A; Cox, MM; Fernandez, P; Huikuri, H; Interian, A; Kessler, KM; Myerburg, RJ; Terracall, E | 1 |
Ou, CN; Rognerud, CL | 1 |
Estes, NA; Manolis, AS | 1 |
Morganroth, J; Nestico, PF | 2 |
Berry, DA; Borrell, G; Conard, GJ; Harrison, LI; Holtzman, JL; Kvam, DC; Mottonen, L | 1 |
Alboni, P; Candini, GC; Cappato, R; Paparella, N | 1 |
Anticoli Borza, S; Bargellini, F; Carolis, S; Casciani, M; Podestà, M | 1 |
Scheininger, M; Stern, H; Theisen, F; Theisen, K | 1 |
Berry, DA; Borrell, G; Holtzman, JL; Kvam, DC; Mottonen, L | 1 |
Holtzman, JL; Lewis, GP | 1 |
Facchini, M; Lazzarotti, M; Schwartz, PJ; Stramba-Badiale, M | 1 |
Malfatto, G; Pessano, P; Schwartz, PJ; Zaza, A | 1 |
Dhein, S; Gerwin, R; Klaus, W; Müller, A | 1 |
De Giovanni, JV | 1 |
Camm, AJ; de Jonghe, D; Debbas, NM; Jackson, SH; Robert, A | 1 |
Citra, M; Freedman, TB; Long, F; Nafie, LA | 1 |
Iwamoto, M; Kobayashi, H; Niimura, I; Nishizawa, T; Sakon, T; Shibata, T; Takigiku, K; Yasui, K; Yokoyama, U | 1 |
Alboni, P; Bottoni, N; Brignole, M; Cappato, R; Fucà, G; Menozzi, C; Paparella, N; Tomasi, C | 1 |
Nagata, Y | 1 |
Kanke, M; Sugiyama, T; Tsuchimoto, K; Yoshiyama, Y | 1 |
Bonanomi, C; Centola, M; Colli, AM; Danzi, GB; Ferlini, M; Galli, MA; Ravaglia, R; Salice, P; Salvini, L | 1 |
Aziz, PF; Pass, RH; Shah, MJ; Tanel, RE; Vetter, VL; Vogel, RL; Wieand, TS; Zelster, IJ | 1 |
Imamura, T; Ninomiya, Y; Tanaka, Y; Yoshinaga, M | 1 |
Álvarez-Fernández, L; Brañas-Fernández, FM; Cortés-Laíño, JA; da Silva-Franca, CF; Nogueira-Fernández, V; Pego-Reigosa, R; Ramos-Rúa, L | 1 |
Akdeniz, C; Ergül, Y; Özyılmaz, İ; Saygı, M; Tola, HT; Tuzcu, V | 1 |
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
Cioppa, ND; Ciriello, GD; Colonna, D; Correra, A; Palladino, MT; Papaccioli, G; Romeo, E; Russo, MG; Sarubbi, B | 1 |
Jee, G; Ofoe, V; Uzun, O; Wong, A | 1 |
Charrabi, A; Chen, S; Cheung, JW; Colombani, S; Evans, T; Jaffré, F; Lacampagne, A; Lerman, BB; Marks, AR; Meli, AC; Pasquié, JL; Reiken, S; Sittenfeld, LR; Sleiman, Y | 1 |
5 review(s) available for propranolol and flecainide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
[Paroxysmal atrial fibrillation within the context of cluster headaches].
Topics: Amiodarone; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Autonomic Nervous System Diseases; Cluster Headache; Flecainide; Humans; Hypothalamus, Posterior; Male; Middle Aged; Models, Neurological; Oxygen Inhalation Therapy; Propranolol; Trigeminal Nerve | 2015 |
3 trial(s) available for propranolol and flecainide
Article | Year |
---|---|
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Patient Readmission; Propranolol; Self Administration; Self Care; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Treatment Outcome | 2001 |
Flecainide augments muscle sympathetic nerve activity in humans.
Topics: Adult; Anti-Arrhythmia Agents; Blood Pressure; Diastole; Electrocardiography; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Propranolol; Reference Values; Sympathetic Nervous System; Systole; Vascular Resistance | 2002 |
45 other study(ies) available for propranolol and flecainide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Supraventricular tachycardia resistant to treatment in a pregnant woman.
Topics: Adult; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Countershock; Female; Flecainide; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol; Tachycardia, Supraventricular | 1992 |
Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium.
Topics: Action Potentials; Animals; Dogs; Electrophysiology; Endocardium; Female; Flecainide; Heart Ventricles; In Vitro Techniques; Male; Membrane Potentials; Pericardium; Propranolol; Sodium Channels; Tetrodotoxin | 1991 |
Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Bradycardia; Consciousness; Diuretics; Dogs; Electrocardiography, Ambulatory; Electrolytes; Electrophysiology; Female; Flecainide; Heart Block; Hypocalcemia; Lidocaine; Male; Propranolol; Quinidine; Sotalol | 1991 |
Increased pacing threshold after an automatic defibrillator shock in dogs: effects of class I and class II antiarrhythmic drugs.
Topics: Animals; Cardiac Catheterization; Cardiac Pacing, Artificial; Dogs; Electric Conductivity; Electric Countershock; Electrocardiography; Flecainide; Heart; Propranolol; Time Factors | 1988 |
Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Encainide; Flecainide; Humans; Male; Middle Aged; Propranolol; Tachycardia | 1989 |
Concurrent measurement of flecainide acetate and propranolol by normal-phase high-performance liquid chromatography.
Topics: Blood Chemical Analysis; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Flecainide; Humans; Propranolol | 1989 |
Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Electrophysiology; Female; Flecainide; Follow-Up Studies; Humans; Isoproterenol; Male; Middle Aged; Monitoring, Physiologic; Propranolol; Wolff-Parkinson-White Syndrome | 1989 |
The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: effects on cardiac function and drug clearance.
Topics: Adult; Blood Pressure; Drug Synergism; Flecainide; Heart Rate; Hemodynamics; Humans; Male; Metabolic Clearance Rate; Middle Aged; Propranolol | 1987 |
Direct and autonomically mediated effects of oral flecainide.
Topics: Administration, Oral; Adult; Aged; Atropine; Autonomic Nervous System; Depression, Chemical; Electrophysiology; Female; Flecainide; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Propranolol | 1988 |
[Wolff-Parkinson-White syndrome and anesthesia].
Topics: Adult; Amiodarone; Anesthesia, General; Female; Flecainide; Humans; Propranolol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 1987 |
Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Piperidines; Propranolol | 1985 |
Application of second-order polynomial equations to the study of pharmacodynamic interactions: the effect of flecainide acetate and propranolol on cardiac output and vascular resistance.
Topics: Adult; Anti-Arrhythmia Agents; Cardiac Output; Drug Interactions; Flecainide; Humans; Male; Middle Aged; Piperidines; Propranolol; Statistics as Topic; Vascular Resistance | 1984 |
Interaction of flecainide with digoxin and propranolol.
Topics: Adult; Digoxin; Drug Interactions; Electrocardiography; Flecainide; Half-Life; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Piperidines; Propranolol | 1984 |
Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
Topics: Animals; Autonomic Nervous System; Cardiac Complexes, Premature; Cats; Electrocardiography; Flecainide; Heart Conduction System; Hemodynamics; Myocardial Ischemia; Propranolol; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
Experimental evidence for beta adrenergic blocking properties of propafenone and for their potential clinical relevance.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cats; Electric Stimulation; Electrocardiography; Female; Flecainide; Heart Rate; Male; Propafenone; Propranolol | 1993 |
Comparative study on the proarrhythmic effects of some antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Flecainide; Male; Osmolar Concentration; Pericardium; Propranolol; Rabbits; Time Factors | 1993 |
Flecainide levels--a cautionary note.
Topics: Anti-Arrhythmia Agents; Child, Preschool; Chromatography, Gas; Female; Flecainide; Humans; Propranolol | 1997 |
Human atrial repolarization: effects of sinus rate, pacing and drugs on the surface electrocardiogram.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atropine; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; Flecainide; Heart Atria; Heart Block; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Propranolol; Reproducibility of Results | 1999 |
Hydrogen-stretching vibrational circular dichroism spectroscopy: absolute configuration and solution conformation of selected pharmaceutical molecules.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Circular Dichroism; Flecainide; Hydrogen; Ibuprofen; Models, Molecular; Molecular Conformation; Molecular Structure; Naphthalenes; Naproxen; Propranolol; Pyrrolidinones; Quinidine; Vibration | 1999 |
Idiopathic sustained left ventricular tachycardia in pediatric patients.
Topics: Adolescent; Anti-Arrhythmia Agents; Child; Child, Preschool; Electrophysiology; Female; Flecainide; Follow-Up Studies; Humans; Male; Prognosis; Propranolol; Tachycardia, Ventricular; Treatment Outcome; Verapamil | 2001 |
Drug-drug interactions between antiarrhythmic drugs in chick embryos.
Topics: Animals; Anti-Arrhythmia Agents; Chick Embryo; Drug Interactions; Electrocardiography; Flecainide; Heart Rate; Procainamide; Propranolol | 2004 |
Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Flecainide; Humans; Infant, Newborn; Infusions, Intravenous; Male; Pilot Projects; Propranolol; Prospective Studies; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Time Factors; Treatment Outcome | 2009 |
Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrioventricular Block; Child; Child, Preschool; Cohort Studies; Defibrillators, Implantable; Female; Flecainide; Genotype; Humans; Infant; Infant, Newborn; Long QT Syndrome; Male; Mexiletine; Multivariate Analysis; Prognosis; Propanolamines; Propranolol; Retrospective Studies; Risk Assessment; Risk Factors; Torsades de Pointes; Treatment Outcome | 2010 |
Combination of flecainide and propranolol for congenital junctional ectopic tachycardia.
Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Flecainide; Humans; Infant; Male; Propranolol; Tachycardia, Ectopic Junctional | 2015 |
The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Propanolamines; Propranolol; Retrospective Studies; Tachycardia, Supraventricular; Treatment Outcome | 2015 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Flecainide; Humans; Infant; Infant, Newborn; Propranolol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular | 2023 |
Wide complex rhythm in a well neonate: Where are the P waves?
Topics: Arrhythmias, Cardiac; Electrocardiography; Flecainide; Heart Ventricles; Humans; Infant, Newborn; Propranolol | 2023 |
Personalized medicine in the dish to prevent calcium leak associated with short-coupled polymorphic ventricular tachycardia in patient-derived cardiomyocytes.
Topics: Anti-Arrhythmia Agents; Calcium; Flecainide; Humans; Myocytes, Cardiac; Precision Medicine; Propranolol; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Verapamil | 2023 |